Garofalo Health Care Statistics

Total Valuation

Garofalo Health Care has a market cap or net worth of EUR 465.84 million. The enterprise value is 688.15 million.

Market Cap	465.84M
Enterprise Value	688.15M

Important Dates

The next estimated earnings date is Monday, March 17, 2025.

Earnings Date	Mar 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Garofalo Health Care has 88.56 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	88.56M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	11.89%
Owned by Institutions (%)	8.14%
Float	26.45M

Valuation Ratios

The trailing PE ratio is 22.26 and the forward PE ratio is 17.74.

PE Ratio	22.26
Forward PE	17.74
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	28.81
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.26, with an EV/FCF ratio of 42.55.

EV / Earnings	32.89
EV / Sales	1.53
EV / EBITDA	9.26
EV / EBIT	13.61
EV / FCF	42.55

Financial Position

The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.70.

Current Ratio	1.12
Quick Ratio	0.96
Debt / Equity	0.70
Debt / EBITDA	3.13
Debt / FCF	14.36
Interest Coverage	3.55

Financial Efficiency

Return on equity (ROE) is 6.73% and return on invested capital (ROIC) is 6.08%.

Return on Equity (ROE)	6.73%
Return on Assets (ROA)	4.16%
Return on Invested Capital (ROIC)	6.08%
Return on Capital Employed (ROCE)	7.19%
Revenue Per Employee	162,751
Profits Per Employee	7,562
Employee Count	2,767
Asset Turnover	0.60
Inventory Turnover	65.82

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.79% in the last 52 weeks. The beta is 0.41, so Garofalo Health Care's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	+8.79%
50-Day Moving Average	5.42
200-Day Moving Average	5.30
Relative Strength Index (RSI)	48.25
Average Volume (20 Days)	24,835

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Garofalo Health Care had revenue of EUR 450.33 million and earned 20.92 million in profits.

Revenue	450.33M
Gross Profit	92.82M
Operating Income	50.36M
Pretax Income	30.10M
Net Income	20.92M
EBITDA	71.29M
EBIT	50.36M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 21.04 million in cash and 232.25 million in debt, giving a net cash position of -211.21 million or -2.38 per share.

Cash & Cash Equivalents	21.04M
Total Debt	232.25M
Net Cash	-211.21M
Net Cash Per Share	-2.38
Equity (Book Value)	329.94M
Book Value Per Share	n/a
Working Capital	16.28M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 32.73 million and capital expenditures -16.56 million, giving a free cash flow of 16.17 million.

Operating Cash Flow	32.73M
Capital Expenditures	-16.56M
Free Cash Flow	16.17M
FCF Per Share	0.18

Full Cash Flow Statement

Margins

Gross margin is 20.61%, with operating and profit margins of 11.18% and 4.65%.

Gross Margin	20.61%
Operating Margin	11.18%
Pretax Margin	6.68%
Profit Margin	4.65%
EBITDA Margin	15.83%
EBIT Margin	11.18%
FCF Margin	3.59%

Dividends & Yields

Garofalo Health Care does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	4.49%
FCF Yield	3.47%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Garofalo Health Care has an Altman Z-Score of 1.3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.3
Piotroski F-Score	n/a